145 related articles for article (PubMed ID: 18345545)
21. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.
Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD;
Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
[TBL] [Abstract][Full Text] [Related]
23. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
[TBL] [Abstract][Full Text] [Related]
24. Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study.
Vermeulen BD; Jeene PM; Sijben J; Krol R; Rütten H; Bogers JA; Braam PM; Siersema PD
Pract Radiat Oncol; 2020; 10(4):e255-e263. PubMed ID: 31669401
[TBL] [Abstract][Full Text] [Related]
25. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
[TBL] [Abstract][Full Text] [Related]
26. Brachytherapy in oesophageal carcinoma.
Leung JT; Kuan R
Australas Radiol; 1995 Nov; 39(4):375-8. PubMed ID: 8561713
[TBL] [Abstract][Full Text] [Related]
27. Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Tambaro R; Mignogna S; Padula GD; Musacchio M; Flocco M; Cantore G; Scapati A; Bogale S; Balducci M; Valentini V; Cellini N; Morganti AG
Am J Clin Oncol; 2015 Aug; 38(4):395-400. PubMed ID: 26214084
[TBL] [Abstract][Full Text] [Related]
28. Esophageal stenting and radiotherapy: a multimodal approach for the palliation of symptomatic malignant dysphagia.
Rueth NM; Shaw D; D'Cunha J; Cho C; Maddaus MA; Andrade RS
Ann Surg Oncol; 2012 Dec; 19(13):4223-8. PubMed ID: 22752374
[TBL] [Abstract][Full Text] [Related]
29. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus.
Powell ME; Hoskin PJ; Saunders MI; Foy CJ; Dische S
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):133-6. PubMed ID: 9212014
[TBL] [Abstract][Full Text] [Related]
30. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.
Wenger U; Johnsson E; Bergquist H; Nyman J; Ejnell H; Lagergren J; Ruth M; Lundell L
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1369-77. PubMed ID: 16292092
[TBL] [Abstract][Full Text] [Related]
31. [Brachytherapy for oesophageal cancer].
Wong S; Hennequin C; Quero L
Cancer Radiother; 2013 Apr; 17(2):159-61. PubMed ID: 23603254
[TBL] [Abstract][Full Text] [Related]
32. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
Bjerring OS; Pless T; Fristrup C; Mortensen MB
Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
[TBL] [Abstract][Full Text] [Related]
33. A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Padula GD; Mignogna S; Tambaro R; Carrozza F; Flocco M; Cantore G; Scapati A; Buwenge M; Sticca G; Valentini V; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e463-8. PubMed ID: 22909415
[TBL] [Abstract][Full Text] [Related]
34. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.
Sabharwal T; Hamady MS; Chui S; Atkinson S; Mason R; Adam A
Gut; 2003 Jul; 52(7):922-6. PubMed ID: 12801944
[TBL] [Abstract][Full Text] [Related]
35. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
36. Short-Course External Beam Radiotherapy Versus Brachytherapy for Palliation of Dysphagia in Esophageal Cancer: A Matched Comparison of Two Prospective Trials.
Jeene PM; Vermeulen BD; Rozema T; Braam PM; Lips I; Muller K; van Kampen D; Homs MYV; Oppedijk V; Berbée M; van Rossum PSN; El Sharouni S; Siersema PD; Hulshof MCCM;
J Thorac Oncol; 2020 Aug; 15(8):1361-1368. PubMed ID: 32407795
[TBL] [Abstract][Full Text] [Related]
37. The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer.
Caspers RJ; Welvaart K; Verkes RJ; Hermans J; Leer JW
Radiother Oncol; 1988 May; 12(1):15-23. PubMed ID: 2457230
[TBL] [Abstract][Full Text] [Related]
38. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
Sharma V; Mahantshetty U; Dinshaw KA; Deshpande R; Sharma S
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):310-5. PubMed ID: 11872275
[TBL] [Abstract][Full Text] [Related]
39. What Did the Pandemic Teach Us About Palliative Radiation in Head and Neck Cancer?
Ghoshal S; Singla AK; Ballari N; Gupta A
J Palliat Care; 2022 Jul; 37(3):317-322. PubMed ID: 34866493
[No Abstract] [Full Text] [Related]
40. Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy.
Grazziotin Reisner R; Reisner ML; Ferreira MA; Rosa AA; Veras IM; Carneiro TM; Wolff B; Viégas CM; Mendonça de Araújo CM; Marchiori E
Brachytherapy; 2015; 14(1):84-90. PubMed ID: 25447340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
